Overview

Study of SM-88 in Advanced Cancers

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect response and pharmacokinetic data on the oral administration of a cocktail combination of 4 drugs being developed for the indication of metastatic breast cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tyme, Inc